Allergic inflammation is orchestrated by antigen-specific CD4 ϩ T cells, eosinophils and mast cells, and is a characteristic feature of bronchial asthma, rhinitis and atopic dermatitis.
We have assessed the release of histamine from mast cells by smooth muscle contraction. 0.3 m mg/ml compound 48/80 showed no effect on concentration-response relationship of histamine in rabbit aorta. Compound 48/80 induced release of histamine from rat mast cells. When aorta was stimulated by compound 48/80 in the presence of mast cells, contraction was evoked in concentration-dependent manner. This mast cell-dependent contraction was completely blocked by H 1 receptor antagonist, 1 m mM diphenhydramine. When mast cells was treated with compound 48/80 inhibitor benzalkonium chloride, mast cell-dependent contraction was inhibited, although benzalkonium chloride itself showed no effect on concentration-response relationship of histamine in rabbit aorta. At high concentration of 10 m mg/ml, benzalkonium chloride itself evoked histamine release from mast cells and indeed inhibitory effect of 10 m mg/ml benzalkonium chloride on mast cell-dependent contraction was lower than that of 3 m mg/ml. We have applied this bioassay to search anti-allergic ingredient from a total methanolic extract of Corydalis tuber (Corydalis turtschaninovii BESSER forma yanhusuo Y. H. CHOU et C. C. HSU). Successively, we have isolated five fractions. The fractions I-IV are identified to be corybulbine (1), tetrahydropalmatine (2), corydaline (3) and yuanhunine (4), respectively. Main component of fraction V is the mixture of 3 and canadine (5). Fractions II and V significantly inhibited mast cell-dependent contraction in rabbit aorta as well as inhibited histamine release from rat mast cells. Furthermore, fractions I, III and V inhibited histamine-induced contraction in rabbit aorta at non-competitive manner. From these results, combination of rat mast cells and rabbit aorta is good bioassay to search the anti-allergic ingredient, and we have obtained effective fractions from Corydalis tuber using this assay.
Measurement of Histamine-Release 1.8 ml of mast cell suspensions are preincubated for 5 min at 37°C before applying 0.1 ml of test solution. After incubating 10 min, mast cells were stimulated by 0.1 ml of compound 48/80 for 10 min. Histamine-release were terminated by cooling cells in ice. Cells and solution are separated by centrifuge (100ϫ g, 10 min at 4°C), equal volume of 0.8 N HClO 4 and twice volume of 0.4 N HClO 4 was added to supernatant and pellet, respectively. To 1 ml of sample, a mixture of 125 ml of NaOH (5 N), 0.4 g of NaCl and 2.5 ml of n-butanol was added. Then, the samples were centrifuged at 200ϫg for 1 min at room temperature. The upper organic phase was transferred to tubes containing 2 ml of NaOH (0.1 N) saturated with NaCl, and the sample was centrifuged to remove contaminated materials from the organic phase; the procedure was then repeated. Next, the upper organic phase was transferred to tubes containing 2 ml HCl (0.1 N) and 7.6 ml n-heptane. To the 1 ml of the lower aqueous phase, 0.1 ml of NaOH (10 N) was added. The histamine-o-phthalaldehyde (OPT) reaction 7) was carried out by incubation with 0.1 ml of OPT (10 mg/ml methanol) for 4 min at room temperature, and terminated by addition of 0.6 ml HCl (3 N). The fluorescence of the conjugate was assessed at 450 nm emission excitated at 360 nm.
Tissue Preparation The thoracic aorta was prepared from male Japanese White rabbits (3-3.5 kg). The aorta was cut into helical strips, approximately 4 mm wide and 20 mm long. The endothelium was removed by gently rubbing the endothelial surface with cotton pellets. The strips were mounted and suspended in a 1 ml organ bath containing the modified Krebs-Ringer-bicarbonate solution contained (mM), NaCl 120, KCl 4.8, CaCl 2 Force Measurement Muscle tension was recorded isometrically with a force-displacement transducer connected to a polygraph (Nihon Koden, Tokyo, Japan). A passive tension of 1 g was initially applied and tissues were allowed to equilibrate for 60 min. After equilibration, the strips were precontracted with high K ϩ solution made by replacing 60 mM NaCl in the modified Krebs-Ringer-bicarbonate solution by equimolar KCl. After the response reached a steady level the experiment was started. Contractile response to histamine were normalized with that of high K ϩ . The data were fitted to a logistic equation:
where R is a response, A is a concentration of histamine, E max is a maximum response, K is a observed EC 50 (the concentration which cause repines of half maximum) of histamine and n is a Hill's coefficient.
Materials The Corydalis tuber used in this study originated from Corydalis turtschaninovii BESSER forma yanhusuo Y. H. CHOU et C. C. HSU in China. A commercial Corydalis tuber was obtained from Tochimoto (Osaka, Japan). Compound 48/80, benzalkonium chloride, histamine and diphenhydramine were purchased from Sigma-Aldrich (Tokyo, Japan).
Isolation and Identification Dried plant material (3.0 kg) was extracted with MeOH (3 lϫ3) at the room temperature to yield a methanolic extract (39 g) and the extract was suspended in H 2 O and then partitioned with EtOAc. The EtOAcsoluble fraction (12 g) of the methanol extract was subjected to silica gel column chromatography (C 6 H 14 -EtOAc, 7 : 3AE 0 : 1) to give subfractions 1-8. These subfractions were tested by the mast cell based bioassay and found the subfractions 1, 2, 4 and 5 to have positive activities. These active subfractions were continually separated by a series of bioassay-directed chromatographic separations, employing preparative TLC (Silica gel) and reversed-phase semipreparative HPLC on YMC-AM 324 column (ODS, 30ϫ1 cm i.d. stainless column, MeOH-H 2 O, 1 ml/min) to obtain the corybulmine (1, 21.2 mg), tetrahydropalmatine (2, 300.0 mg), corydaline (3, 23.0 mg) and yuanhunine (4, 22.1 mg) and a mixture (40.2 mg). Portions (10.0 mg) of the mixture was further separated by a semipreparative HPLC (YMC-AM 324, ODS, 30ϫ1 cm i.d. stainless column, 45% MeOH in H 2 O, 1 ml/min) to afford corydaline 3 (4.6 mg) and canadine (5, 3.8 mg), respectively.
Corybulmine (1) Tetrahydropalmatine (2) Corydaline (3) Canadine (5) Statistics Results of the experiments are expressed as meansϮS.E.M. Significance was tested with Student's t-test, or Dunnett's multiple comparison test when comparisons involved more than two groups. p values smaller than 0.05 were considered significant.
RESULTS

Mast Cell-Depend Contraction
One milliliter of mast cells suspended in PBS were introduced to organ bath where aorta was suspended. Compound 48/80 evoked contraction in concentration dependent manner and 1 mM diphenhydramine, H 1 receptor antagonist, completely inhibited this contration (Fig. 1) .
In the presence of mast cells, benzalkonium chloride (BAC), a typical inhibitor of histamine-release, 8) inhibited the contraction evoked by 0.3 mg/ml compound 48/80 in rabbit aorta, in concentration-dependent manner (Fig. 2A) . Since Read and Kiefer reported that higher concentration of BAC itself releases histamine, 8) we measured the effect of BAC on histamine-release from mast cell. As a result, only at highest concentration of BAC (10 mg/ml) showed fascilitating effect (Fig. 2B) .
As shown in Fig. 3 , we have assessed the effect of compound 48/80 and BAC with the concentrations which used in this bioassay, on concentration-response relationship of histamine in rabbit aorta. Neither 0.3 mg/ml compound 48/80, 3 mg/ml nor 10 mg/ml BAC had affected on concentractioncontraction relationship of histamine.
Fractionation The methanolic extract from Corydalis tuber was suspended in H 2 O, and partitioned with EtOAc. We assessed each fraction on mast cell-dependent contraction of rabbit aorta (Table 1) .
Each fraction was subfractioned by TLC pattern and finally isolated five fractions using HPLC (Chart 1).
Pharmacological Profile 50 mg/ml of five fractions has applied to study the effect on mast cell-dependent contraction in rabbit aorta (Fig. 4A) . Fractions II and V showed significant inhibition. Fractions II and V also inhibited compound 48/80-induced histamine-release from mast cells (Fig.  4B) .
To evaluate direct effect on smooth muscle, five fractions has applied to concentration-contraction relationship of histamine in rabbit aorta. Fractions I, III and V significantly inhibited the histamine-induced contraction without affecting 1272 Vol. 27, No. 8 EC 50 value of histamine (Table 2) . Fractions II and IV did not significantly but tended to inhibit maximum contraction of histamine (Table 2) .
DISCUSSION
Shore et al. developed the method to quantify histamine in high-sensitivity. 7) This method is well established and oftenly used. The method is composed from 2 steps; 1) purification of amine, and 2) measurement of fluoresence. Therefore, we should be careful for contamination of ingredient of test sample interfering with fluorescence of histamine-OPT condensated product when using this method. Our bioassay is the alternative one, where histamine can be assayed as the contraction of aorta.
It is generally known that compound 48/80 induces histamine release from mast cells without the participation of an immunological mechanism as caused by an antigen-antibody reaction. 9, 10) In our bioassay system, stimulant of mast cell is allowed to be contacted with smooth muscle. From our result, rabbit aorta does not respond to compound 48/80. Therefore, it is safely to use compound 48/80 to stimulate mast cells in this assay.
According to this bioassay, we have successively obtained five fractions from Corydalis tuber. 50 mg/ml of fractions II and V inhibited histamine release and fractions I, III and V inhibited histamine-induced smooth muscle contraction. The main content of fractions I-V were corydaline analogues. Matsuda et al. demonstrated that dehydrocorydaline isolated from Corydalis tuber 11) inhibit some allergic models. Our results suggesting that other corydaline analogues may account for anti-allergic effect of methanolic extract of Corydalis tuber. 5) Since fraction IV showing scarce effect comparing Rabbit aorta was incubated with 50 mg/ml of fractions I-V for 15 min. Subsequently, histamine (0.1-1000 mM) was applied in cumulative manner. **: pϽ0.01.
with fraction V, canadine (5) may account for inhibitory effect of fraction V on histamine release. Furthermore, corybulmine (1), tetrahydropalmatine (2) and corydaline (3) are also the candidate for developing anti-allergic drug. Further studies are required to evaluate the action and the mechanisms of the effects of these compounds on histamine release and anti-histaminergic effect.
The bioassay represented in this manuscript is sensitive to detect both inhibitory effects on activation of mast cell as well as inhibitory effect on histamine-induced smooth muscle contraction. Therefore, one must keep in mind that this is not the simple alternative method for the detection of histamine released from mast cells. This method is complemental to colorimetric method and also it rather will be in vitro model of passive cutaneous anaphylaxis.
From these results, the combination of mast cells and aortic smooth muscle is shown to be good bioassay to search ingredients which affect on histamine-release and/or smooth muscle contraction.
